Franchise opportunities compared
Amerisourcebergen Drug vs Tijon Fragrance Lab
Reviewed figures from each brand's Franchise Disclosure Document (FDD), side by side. Each figure carries its FDD year and page. This is not a ranking or recommendation, and the two FDDs may cover different years and location groups.
Initial investment · Item 7
Amerisourcebergen Drug
$5,000 – $12,000
2026 FDD · Item 7 · PDF p. 29Tijon Fragrance Lab
Not available
Initial franchise fee · Item 5
Amerisourcebergen Drug
Not available
Tijon Fragrance Lab
$29,750
2026 FDD · Item 5 · PDF p. 4Royalty · Item 6
Amerisourcebergen Drug
Not available
Tijon Fragrance Lab
$6.00 Total Gross Receipts
2026 FDD · Item 6 · PDF p. 17Before you compare
- Both sets of figures come from 2026 FDDs.
- Only neither brand has reviewed Item 19 figures here.
Financial commitment
Amerisourcebergen Drug
Tijon Fragrance LabAmerisourcebergen Drug
Tijon Fragrance Lab
Amerisourcebergen Drug
Tijon Fragrance Lab
Amerisourcebergen Drug
Tijon Fragrance Lab
Amerisourcebergen Drug
Tijon Fragrance Lab
System scale & health
Amerisourcebergen Drug
Tijon Fragrance LabAmerisourcebergen Drug
Tijon Fragrance Lab
Amerisourcebergen Drug
Tijon Fragrance Lab
Amerisourcebergen Drug
Tijon Fragrance Lab
Amerisourcebergen Drug
Tijon Fragrance Lab
Amerisourcebergen Drug
Tijon Fragrance Lab
Financial performance (Item 19), by location group
Amerisourcebergen DrugNo reviewed Item 19 figures
Tijon Fragrance LabNot disclosed — no Item 19 financial performance representation
Item 19 groups are shown separately and never combined. Revenue or sales figures are not profit. Net outlet change and turnover are Franopolis calculations from the disclosed counts; turnover is a count-based rate, not a measure of owner earnings.
Amerisourcebergen Drug vs Tijon Fragrance Lab: common questions
- Do Amerisourcebergen Drug and Tijon Fragrance Lab disclose financial performance (Item 19)?
- Amerisourcebergen Drug has no reviewed Item 19 figures on file; Tijon Fragrance Lab makes no Item 19 financial performance representation. Different location groups are not directly comparable, and revenue is not profit.
Answers restate the reviewed figures above. Not a ranking or recommendation.
Keep researching

Full Amerisourcebergen Drug report
Every reviewed fee, Item 19 group, outlet table and territory disclosure

Full Tijon Fragrance Lab report
Every reviewed fee, Item 19 group, outlet table and territory disclosure


